Evidence map›Paper›PMID 37908639›Full record

ArticleHealth science reports2023

The neglected continuously emerging Marburg virus disease in Africa: A global public health threat.

Devang Srivastava, Lakshmi Venkata Simhachalam Kutikuppala, Pooja Shanker, Rudra Narayan Sahoo, Gurudutta Pattnaik, Rasmita Dash, Venkataramana Kandi, Azaj Ansari, Snehasish Mishra, Dhruv N Desai and 3 more

Open access · goldAbstract read
In one paragraph

Article in Health science reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Can Marburg virus be sexually transmitted?Health science reports · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 12 institutions in 5 countries.

Devang SrivastavaDepartment of General Medicine Kakatiya Medical College Rangam Peta Street Warangal Telangana India.
Lakshmi Venkata Simhachalam KutikuppalaDepartment of General Surgery Dr NTR University of Health Sciences Vijayawada Andhra Pradesh India.
Pooja ShankerDepartment of Microbiology SMS Medical College Gangawal Park, Adarsh Nagar Jaipur Rajastan India.
Rudra Narayan SahooSchool of Pharmaceutical Sciences Siksha-O-Anusandhan Deemed-to-be-University Bhubaneswar Odisha India.
Gurudutta PattnaikSchool of Pharmacy and Life Sciences Centurion University of Technology and Management Odisha India.
Rasmita DashSchool of Pharmacy and Life Sciences Centurion University of Technology and Management Odisha India.
Venkataramana KandiDepartment of Microbiology Prathima Institute of Medical Sciences Karimnagar Telangana India.ORCID 0000-0002-7197-0448
Azaj AnsariDepartment of Chemistry Central University of Haryana Mahendergarh Haryana India.
Snehasish MishraSchool of Biotechnology KIIT Deemed-to-be University Bhubaneswar Odisha India.ORCID 0000-0002-3896-5831
Dhruv N DesaiSchool of Veterinary Medicine, Ryan Veterinary Hospital University of Pennsylvania Philadelphia Pennsylvania USA.
Ranjan K MohapatraDepartment of Chemistry Government College of Engineering Keonjhar Odisha India.ORCID 0000-0001-7623-3343
Ali A RabaanMolecular Diagnostic Laboratory Johns Hopkins Aramco Healthcare Dhahran Saudi Arabia.
Md Kudrat-E-ZahanDepartment of Chemistry Rajshahi University Rajshahi Bangladesh.ORCID 0000-0001-8159-5293
Centurion University of Technology and Management · INAlfaisal University · SACentral University of Haryana · INDr. NTR University of Health Sciences · INGovernment College of Engineering, Keonjhar · INHospital of the University of Pennsylvania · USInstitute of Medical Sciences · INKakatiya University · INKIIT University · INSiksha O Anusandhan University · INSMS Medical College · INUniversity of Rajshahi · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aim: Severe viral hemorrhagic fever (VHF) is caused by Marburg virus which is a member of the Filoviridae (filovirus) family. Many Marburg virus disease (MVD) outbreaks are reported in five decades. A major notable outbreak with substantial reported cases of infections and deaths was in 2022 in Uganda. The World Health Organisation (WHO) reported MVD outbreak in Ghana in July 2022 following the detection of two probable VHF patients there. Further, the virus was reported from two other African countries, the Equatorial Guinea (February 2023) and Tanzania (March 2023). There have been 35 deaths out of 40 reported cases in Equatorial Guinea, and six of the nine confirmed cases in Tanzania so far. Methods: Data particularly on the several MVD outbreaks as reported from the African countries were searched on various databases including the Pubmed, Scopus, and Web-of-science. Also, the primary data and reports from health agencies like the WHO and the Centers for Disease Control and Prevention CDC) were evaluated and the efficacy reviewed. Results: Chiroptera in general and bat species like Conclusion: In the face of the lack of effective therapeutics and preventives against MVD, supportive care is the only available option which contributes to the growing concern and disease severity. In view of the preventive approaches involving effective surveillance and monitoring system following the "One Health" model is extremely beneficial to ensure a healthy world for all, this article aims at emphasizing several MVD outbreaks, epidemiology, zoonosis of the virus, current treatment strategies, risk assessments, and the mitigation strategies against MVD.

Indexed as

epidemiologyMarburg virusmitigation strategyone‐Health approachrisk assessmenttherapeuticszoonosis

Identifiers

PMID37908639
PMCPMC10613755
OpenAlexW4388098999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.